Clinical trial · Observational
Fertility Preservation- Oncology Treatment Effects and Psychological Impact
NCT02515916CI-TRIAL-00054774terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Not enough subjects
Summary
Brief summary (as posted)
The purpose of this study is assess the effects of oncology treatment on ovarian reserve and also to better understand the experiences, thoughts and feelings of women scheduled to undergo chemotherapy/radiotherapy and seeking fertility preservation at Weill Cornell Medical College (WCMC).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Not Interventional | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- AMH (anti-mullerian hormone) blood levels
- timeFrame
- Up to 3 years
- description
- To determine if fertility reserve is affected by oncology treatment.
- measure
- Quality of life on the Dyadic Adjustment Scale
- timeFrame
- 3 years
- description
- To determine if there is any psychological impact of oncology treatment.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Women ages 18-45 * Women seeking fertility preservation at WCMC * Women who will undergo oncology treatments that will likely cause reduced fertility potential. Exclusion Criteria: * Women who do not meet the inclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.